Ligand validation:7N9L

PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE

PCW is a Ligand Of Interest in 7N9L designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7N9L_PCW_A_402	10%	90%	0.18	0.831	0.32	0.3	-	-	0	0	17%	0.98
7N9L_PCW_A_401	3%	90%	0.262	0.751	0.32	0.28	-	-	0	0	15%	0.97
7N9L_PCW_A_404	1%	75%	0.349	0.665	0.41	0.57	-	-	0	0	7%	1
7N9L_PCW_A_403	1%	87%	0.478	0.754	0.31	0.38	-	-	0	0	17%	0.812
7N9K_PCW_A_504	2%	90%	0.29	0.747	0.33	0.28	-	-	0	0	13%	1
6ZHH_PCW_B_1009	47%	48%	0.198	0.937	0.99	1.01	5	4	5	0	100%	1
4NAB_PCW_A_1103	30%	57%	0.216	0.881	0.99	0.67	1	2	6	0	100%	1
4F2A_PCW_A_607	26%	40%	0.215	0.857	1.28	1.05	4	6	5	0	100%	1
6JXI_PCW_B_303	25%	49%	0.265	0.903	0.91	1.05	2	3	2	0	100%	1
5NCQ_PCW_A_1003	24%	53%	0.236	0.924	0.95	0.88	-	-	3	0	67%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.